A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia

J. F. Seymour*, D. W. Kim, E. Rubin, A. Haregewoin, J. Clark, P. Watson, T. Hughes, I. Dufva, J. L. Jimenez, F. X. Mahon, P. Rousselot, J. Cortes, G. Martinelli, C. Papayannidis, A. Nagler, F. J. Giles

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint Dive into the research topics of 'A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences